Sales decline 16.67% to Rs 0.10 crore
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.09 crore in the quarter ended September 2020 as against net profit of Rs 0.02 crore during the previous quarter ended September 2019. Sales declined 16.67% to Rs 0.10 crore in the quarter ended September 2020 as against Rs 0.12 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales0.100.12 -17 OPM %-90.0016.67 -PBDT-0.090.02 PL PBT-0.090.02 PL NP-0.090.02 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
